The ATM offering signals near-term capital needs and will dilute existing shareholders. Monitor actual share sale volumes and pace of offerings. If sales are aggressive, expect further downside pressure on NKTR stock.
Price Chart
Executive Summary
Nektar Therapeutics entered into an at-the-market equity distribution agreement to sell up to $150 million of common stock, representing potential dilution of ~6% of market cap. The company also announced the retirement of interim CFO Sandra Gardiner, effective May 15, 2026, to be replaced by Linda Rubinstein, also from FLG Partners.
Key Facts
- Up to $150M aggregate offering price of common stock in at-the-market sales
- Commission of 3.0% of gross sales price to Guggenheim and H.C. Wainwright
- Interim CFO Sandra Gardiner retiring effective May 15, 2026; Linda Rubinstein appointed as interim CFO
- Shares sold at prevailing market prices; no minimum obligation to sell
Financial Impact
Potential dilution of up to ~6% of market cap ($2.5B) with net proceeds after 3% commission
Risk Factors
- Dilution from sale of up to $150M in common stock
- CFO transition may cause short-term uncertainty, though orderly
- ATM may signal cash burn concerns or lack of alternative financing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-214976 |
| Document: d159808d8k.htm | 0001193125-26-214976 |
| Document: d159808dex51.htm | 0001193125-26-214976 |
| Document: 0001193125-26-214976-index-headers.html | 0001193125-26-214976 |
| Document: 0001193125-26-214976-index.html | 0001193125-26-214976 |
| Document: 0001193125-26-214976.txt | 0001193125-26-214976 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 9w ago | Press Release | $73.02 $68.50 | ▼ −6.19% | ▼ −4.20% | $35.78 (−51.00%) |
Aug 9, 2026 10w ago | Institutional Cluster | $74.86 $75.44 | ▲ +0.77% | ▲ +1.69% | $35.78 (−52.20%) |
Aug 7, 2026 10w ago | Court Ruling | $76.48 $74.19 | ▼ −2.99% | ▼ −2.60% | $35.78 (−53.22%) |
Jul 28, 2026 11w ago | Press Release | $70.68 $73.77 | ▲ +4.37% | ▼ −0.65% | $35.78 (−49.38%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
May 21, 2026 21w ago | Insider Cluster | $66.61 $65.25 | ▲ +2.04% | ▲ +0.63% | $35.78 (+46.28%) |
May 8, 2026 23w ago | 8-K | $78.72 $56.23 | ▲ +28.57% | ▲ +28.27% | $35.78 (+54.55%) |
May 7, 2026 23w ago | 8-K | $81.89 $57.32 | ▼ −30.00% | ▼ −30.03% | $35.78 (−56.31%) |
Apr 24, 2026 25w ago | DEFA14A | $86.74 $65.56 | ▼ −24.42% | ▼ −29.37% | $35.78 (−58.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access